A Management Strategy for Giant Cell Tumor of the Metacarpal: A Single-center Series of 11 Cases

Overview

Journal J Clin Orthop Trauma

Specialty Orthopedics

Date 2020 Jul 21

PMID 32684706

Citations 1

Authors

Prakash P Kotwal

Mohammed Tahir Ansari

Asjad Mahmood

Vikas Gupta

Shah Alam Khan

Affiliations

Soon will be listed here.

Abstract

Background: Primary giant cell tumor (GCT) arising from bones of hand are rare to occur. Metacarpals are often the most common site of involvement among hand bones. There are no uniform guidelines for treatment of GCT involving metacarpals due to lack of relevant literature.

Objective: To suggest a management strategy for GCT involving metacarpals.

Methods: Retrospective review of cases of GCT involving metacarpals over a period of 15 years from 2005 to 2019 managed at department of Orthopaedics, All India Institute of Medical Sciences, New Delhi.

Results: A total of 12 cases of GCT involving metacarpal were included, out of which one was lost to follow-up. Four cases were recurrent, and seven were primary at the time of surgery. All the patients were operated with wide excision of the tumor. In seven patients reconstruction of the metacarpal and MCPJ was done using fibular strut graft and silastic artificial joint, while in two patients, MCPJ arthrodesis was performed using fibula and/or iliac crest bone graft. In another two patients, the MCPJ was reconstructed using reversed vascularised toe transfer. Mean follow up of the patients was 3.22 ± 2.07 years. Mean Quick DASH score at latest follow-up of patients operated with silastic joint reconstruction, reversed vascularised toe transfer and arthrodesis of MCP joints were 30.5 ± 9.5, 25 ± 2.3 and 39.8 ± 3.4 respectively. Local recurrence occurred only in one patient at one year after surgery. All the patients were pain free at latest follow-up with quite functional and cosmetically acceptable hand.

Conclusion: Reversed vascularised metatarsal transfer has obtained better functional results compared to reconstruction with fibular grafting and silicone joint replacement but due to technical difficulties, vascularised joint transfer may not be performed in every setting and there is risk of donor site morbidities with this technique. Our strategy for the treatment of GCT involving metacarpal was to do vascularised joint transfer or arthrodesis for border digits and reconstruction with silicone joint for central digits.

Citing Articles

3D-printed personalised prostheses for bone defect repair and reconstruction following resection of metacarpal giant cell tumours.

Xu L, Qin H, Cheng Z, Jiang W, Tan J, Luo X Ann Transl Med. 2021; 9(18):1421.

PMID: 34733973 PMC: 8506718. DOI: 10.21037/atm-21-3400.

References

Wittig J, Simpson B, Bickels J, Malawer M . Giant cell tumor of the hand: superior results with curettage, cryosurgery, and cementation. J Hand Surg Am. 2001; 26(3):546-55. DOI: 10.1053/jhsu.2001.22525. View

Kotwal P, Nagaraj C, Gupta V . Vascularised joint transfer in the management of recurrent giant cell tumour of the second metacarpal. J Hand Surg Eur Vol. 2008; 33(3):314-6. DOI: 10.1177/1753193408089048. View

Kanaya K, Wada T, Usui M, Yamashita T . Fourteen-year results of a reversed vascularized second metatarsophalangeal joint transfer: a case report. J Hand Surg Am. 2005; 30(1):120-4. DOI: 10.1016/j.jhsa.2004.08.008. View

Biscaglia R, Bacchini P, Bertoni F . Giant cell tumor of the bones of the hand and foot. Cancer. 2000; 88(9):2022-32. DOI: 10.1002/(sici)1097-0142(20000501)88:9<2022::aid-cncr6>3.0.co;2-y. View

Dingels W, Rolle H . [Case report of a giant cell tumor of the second metacarpal bone and implantation of a cement prosthesis]. Handchirurgie. 1979; 11(3-4):251-4. View

Ropars M, Kaila R, Cannon S, Briggs T . Primary giant cell tumours of the digital bones of the hand. J Hand Surg Eur Vol. 2007; 32(2):160-4. DOI: 10.1016/J.JHSB.2006.11.009. View

Ansari M, Kotwal P, Rao S . Reconstruction with fibular autograft and silicone implant arthroplasty after resection of giant-cell tumour of the proximal phalanx: a case report with 18-month follow-up. Musculoskelet Surg. 2013; 98(2):153-7. DOI: 10.1007/s12306-013-0243-6. View

Averill R, Smith R, Campbell C . Giant-cell tumors of the bones of the hand. J Hand Surg Am. 1980; 5(1):39-50. DOI: 10.1016/s0363-5023(80)80042-6. View

. Recurrent metacarpal giant cell tumour treated by en bloc resection and metatarsal transfer. J Hand Surg Br. 1998; 23(2):275-8. DOI: 10.1016/s0266-7681(98)80197-6. View

10.

James S, Davies A . Giant-cell tumours of bone of the hand and wrist: a review of imaging findings and differential diagnoses. Eur Radiol. 2005; 15(9):1855-66. DOI: 10.1007/s00330-005-2762-5. View

11.

Williams J, Hodari A, Janevski P, Siddiqui A . Recurrence of giant cell tumors in the hand: a prospective study. J Hand Surg Am. 2010; 35(3):451-6. DOI: 10.1016/j.jhsa.2009.12.004. View

12.

Punyaratabandhu T, Lohwongwatana B, Puncreobutr C, Kosiyatrakul A, Veerapan P, Luenam S . A Patient-Matched Entire First Metacarpal Prosthesis in Treatment of Giant Cell Tumor of Bone. Case Rep Orthop. 2017; 2017:4101346. PMC: 5494097. DOI: 10.1155/2017/4101346. View

13.

Athanasian E, Wold L, Amadio P . Giant cell tumors of the bones of the hand. J Hand Surg Am. 1997; 22(1):91-8. DOI: 10.1016/S0363-5023(05)80187-X. View

14.

Campanacci M, Baldini N, Boriani S, Sudanese A . Giant-cell tumor of bone. J Bone Joint Surg Am. 1987; 69(1):106-14. View

15.

Dahlin D . Giant-cell-bearing lesions of bone of the hands. Hand Clin. 1987; 3(2):291-7. View

16.

Saikia K, Bhuyan S, Ahmed F, Chanda D . Giant cell tumor of the metacarpal bones. Indian J Orthop. 2011; 45(5):475-8. PMC: 3162689. DOI: 10.4103/0019-5413.83957. View

17.

Sobti A, Agrawal P, Agarwala S, Agarwal M . Giant Cell Tumor of Bone - An Overview. Arch Bone Jt Surg. 2016; 4(1):2-9. PMC: 4733230. View

18.

Sanjay B, Raj G, Younge D . Giant cell tumours of the hand. J Hand Surg Br. 1996; 21(5):683-7. DOI: 10.1016/s0266-7681(96)80161-6. View